healthcare

healthcare Articles

The March 31 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
The March 31 short interest data has been compared with the previous report, and short interest in these selected biotech stocks shrank.
Across the country, there have been more than 22,000 COVID-19 deaths so far, out of over 561,000 confirmed cases. Wyoming so far has reported no deaths due to the disease.
Tiziana Life Sciences and CleanSpark were two of the biggest stock winners on Thursday after each company provided an update on what it is doing to fight the novel coronavirus.
Pfizer and BioNTech each saw gains on Thursday after the companies announced additional details regarding their collaboration in the fight against COVID-19.
Moleculin Biotech shares absolutely exploded on Wednesday after the company gave an update on its coronavirus treatment.
GenMark Diagnostics shares shot up early on Wednesday after the company provided an update on its quarterly numbers and where it stands with its coronavirus test.
Co-Diagnostics shares popped on Monday after the company announced a key update from the FDA on its COVID-19 test kit.
Immunomedics shares soared on Monday after the announcements that a late-stage breast cancer study was halted early and a new chief executive officer was named.
In a recent report from Wedbush Securities, the boutique brokerage firm recaps the COVID-19 impact on its coverage universe. Here, 24/7 Wall St. has picked out some of Wedbush’s top picks within...
ElectroCore shares absolutely exploded on Friday after the company announced an update for its COVID-19 treatment.
Walgreens Boots Alliance released better than expected fiscal second-quarter financial results before the markets opened on Thursday.
Becton, Dickinson is officially throwing its hat in the ring to fight COVID-19. Specifically, this firm is working on the front end by testing for the disease and antibodies that have been built up...
InflaRx shares jumped early on Wednesday after the company announced that it has enrolled its first patient into a clinical trial for the treatment of severe COVID-19-induced pneumonia.
Co-Diagnostics is on many shortlists of companies with partial medical solutions to slow the coronavirus outbreak. Investors have been on a roller-coaster ride. Is the stock ready to run?